Self-Monitoring Of Blood Glucose (SMBG) is one of the greatest advancements that has taken place in the management of Diabetes.
The cost of treating diabetes in the United States reached $132 billion in the year 2002. In India the incidence of diabetes over the last decade has risen significantly. The two great advancements in the management of 'Diabetes Mellitus' in the last hundred years have been the discovery of insulin in 1922, and the development of self-monitoring of blood glucose (SMBG) levels in 1978.
The current advancement has made self-monitoring very simple and fairly accurate. SMBG makes it simple for patients to get an FBG (fasting blood glucose) or PPBG (post prandial blood glucose) checked at home without the need to visit a laboratory or visit a diabetologist to get their medications altered.
Blood testing for sugar (carbohydrate in food gets converted to glucose in the blood) is a more direct and accurate method of checking the level of glucose in the body. Sugars can also be checked in the urine but this is an indirect method and does not accurately reflect the control of sugar in the body.
- Self-monitoring Blood Glucose (SMBG): Now and the Future -Amber L. Briggs,Journal of Pharmacy Practice, Vol. 17, No. 1, 29-38 (2004)
- Heagarty, Margaret C. Life-style change: a difficult challenge. Pediatrics. 1976; 58:314-5.
Latest Publications and Research on Diabetes - Self-Monitoring of Blood Glucose (SMBG)
- The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial. - Published by PubMed
- The Effect of LM25 and LM50 on Hypoglycemia in Chinese T2DM Patients: Post Hoc Analysis of a Randomized Crossover Trial. - Published by PubMed
- USE OF CONTINUOUS GLUCOSE MONITORING LEADS TO DIAGNOSIS OF HEMOGLOBIN C TRAIT IN A PATIENT WITH DISCREPANT HEMOGLOBIN A1C AND SELF-MONITORED BLOOD GLUCOSE. - Published by PubMed
- Reinforcement Learning-Based Adaptive Insulin Advisor for Individuals with Type 1 Diabetes Patients under Multiple Daily Injections Therapy. - Published by PubMed
- Benefits and limitations of continuous glucose monitoring in type 1 diabetes. - Published by PubMed